| Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease DB Jump, KA Lytle, CM Depner, S Tripathy Pharmacology & therapeutics 181, 108-125, 2018 | 139 | 2018 |
| Potential for dietary ω-3 fatty acids to prevent nonalcoholic fatty liver disease and reduce the risk of primary liver cancer DB Jump, CM Depner, S Tripathy, KA Lytle Advances in Nutrition 6 (6), 694-702, 2015 | 104 | 2015 |
| Docosahexaenoic acid blocks progression of western diet-induced nonalcoholic steatohepatitis in obese Ldlr-/- mice KA Lytle, CP Wong, DB Jump PloS one 12 (4), e0173376, 2017 | 61 | 2017 |
| Fatty acid elongase-5 (Elovl5) regulates hepatic triglyceride catabolism in obese C57BL/6J mice [S] S Tripathy, KA Lytle, RD Stevens, JR Bain, CB Newgard, AS Greenberg, ... Journal of lipid research 55 (7), 1448-1464, 2014 | 58 | 2014 |
| Docosahexaenoic acid attenuates Western diet-induced hepatic fibrosis in Ldlr−/− mice by targeting the TGFβ-Smad3 pathway KA Lytle, CM Depner, CP Wong, DB Jump Journal of lipid research 56 (10), 1936-1946, 2015 | 47 | 2015 |
| Impact of dietary fat on the development of non-alcoholic fatty liver disease in Ldlr−/− mice DB Jump, CM Depner, S Tripathy, KA Lytle Proceedings of the Nutrition Society 75 (1), 1-9, 2016 | 44 | 2016 |
| Is Western Diet-Induced Nonalcoholic Steatohepatitis in Ldlr-/- Mice Reversible? KA Lytle, DB Jump PloS one 11 (1), e0146942, 2016 | 42 | 2016 |
| Adipose tissue inflammation is not related to adipose insulin resistance in humans AE Espinosa De Ycaza, E Søndergaard, M Morgan-Bathke, K Lytle, ... Diabetes 71 (3), 381-393, 2022 | 32 | 2022 |
| Insulin-stimulated muscle glucose uptake and insulin signaling in lean and obese humans PA Ramos, KA Lytle, D Delivanis, S Nielsen, NK LeBrasseur, MD Jensen The Journal of Clinical Endocrinology & Metabolism 106 (4), 1631-1646, 2021 | 30 | 2021 |
| Effects of calcium salts of soybean oil on factors that influence pregnancy establishment in Bos indicus beef cows RF Cooke, BI Cappellozza, TA Guarnieri Filho, CM Depner, KA Lytle, ... Journal of Animal Science 92 (5), 2239-2250, 2014 | 30 | 2014 |
| Hepatic fatty acid balance and hepatic fat content in humans with severe obesity KA Lytle, NC Bush, JM Triay, TA Kellogg, ML Kendrick, JM Swain, ... The Journal of Clinical Endocrinology & Metabolism 104 (12), 6171-6181, 2019 | 29 | 2019 |
| Effects of protein supplementation frequency on physiological responses associated with reproduction in beef cows BI Cappellozza, RF Cooke, MM Reis, RS Marques, TA Guarnieri Filho, ... Journal of animal science 93 (1), 386-394, 2015 | 27 | 2015 |
| A Lipidomic Analysis of Docosahexaenoic Acid (22:6, ω3) Mediated Attenuation of Western Diet Induced Nonalcoholic Steatohepatitis in Male Ldlr -/- Mice M García-Jaramillo, KA Lytle, MH Spooner, DB Jump Metabolites 9 (11), 252, 2019 | 24 | 2019 |
| Senescent cells in human adipose tissue: a cross‐sectional study AE Espinosa De Ycaza, E Søndergaard, M Morgan‐Bathke, ... Obesity 29 (8), 1320-1327, 2021 | 20 | 2021 |
| Ceramide concentrations in liver, plasma, and very low‐density lipoproteins of humans with severe obesity KA Lytle, JO Chung, NC Bush, JM Triay, MD Jensen Lipids 58 (3), 107-115, 2023 | 4 | 2023 |
| Adipocyte proteins and storage of endogenous fatty acids in visceral and subcutaneous adipose tissue in severe obesity KA Lytle, NC Bush, JM Triay, TA Kellogg, ML Kendrick, JM Swain, ... Obesity 29 (6), 1014-1021, 2021 | 4 | 2021 |
| The Soluble Fiber α-Cyclodextrin Does Not Increase the Fecal Losses of Dietary Fat in Adults—A Double-Blind, Randomized, Placebo-Controlled, Crossover Trial KA Lytle, DA Harteneck, AM Noble, MD Jensen The Journal of Nutrition 148 (9), 1421-1425, 2018 | 4 | 2018 |
| 13 ω-3 Fatty Acids and Nonalcoholic Fatty Liver Disease CM Depner, KA Lytle, S Tripathy, DB Jump Liver Metabolism and Fatty Liver Disease, 247, 2014 | 3 | 2014 |
| DHA and Low-fat Low-cholesterol Diets as Treatment Strategies for Nonalcoholic Fatty Liver Disease KA Lytle | 1 | 2016 |
| Dietary docosahexaenoic acid (DHA) halts progression of nonalcoholic steatohepatitis (NASH), but does not promote fibrosis remission in Ldlr−/− mice KA Lytle, C Wong, D Jump The FASEB Journal 30, 870.2-870.2, 2016 | 1 | 2016 |
